Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 22, 2024Biomedical ReportsOpen Access

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNan ShenJQJibing QiaoYJYazhou Jiang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shen et al. (2024) studied this question.

synapsesocial.com/papers/6a82e6f757df60cfb510c665https://doi.org/10.3892/br.2024.1732
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1[The efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia].2018 · 6 citations
  2. 2Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists2019 · 50 citations
  3. 3Thrombosis in immune thrombocytopenia — current status and future perspectives2021 · 63 citations
  4. 4Thrombosis and platelets: an update2016 · 458 citations
  5. 5Is <scp>ITP</scp> a thrombophilic disorder?2015 · 157 citations